Beam Therapeutics· @BeamTx · X·· 14 天前AI 评分22
AI 导读
今日,Beam公布了2026年第三季度财务业绩,并介绍了公司血液疾病与遗传疾病业务板块的最新进展。
正文
Today, Beam reported third quarter 2026 financial results and provided updates across the company’s hematology and genetic disease franchises.
来源:Beam Therapeutics · x.com